Myelodysplastic syndromes (MDS) are blood cancers where bone marrow makes atypical red cells, white cells, or platelets. These cells may die early or not work well. Less aggressive MDS may still allow ...
After a brief introduction, medical experts discuss advances in MDS classification and molecular understanding. Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results